Iqvia Holdings IncChange company Symbol lookupSelect an option...IQV Iqvia Holdings IncEVRG Evergy IncTTWO Take-Two Interactive Software IncCLVS Clovis Oncology IncVNCE Vince Holding CorpCREE Cree IncNDSN Nordson CorpCIEN Ciena CorpFTSV Forty Seven IncKZR Kezar Life Sciences IncGo
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
|
|
|
|
|
IQV's position in the Life Sciences Tools & Services industry
| Industry Peers | PRAH | CRL | SYNH | MEDP | |
|---|---|---|---|---|---|
Summary | |||||
| Company Profile | IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial... | PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers... Go to PRAH summary | Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop... Go to CRL summary | Syneos Health, Inc., formerly INC Research Holdings, Inc., is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the... Go to SYNH summary | Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with... Go to MEDP summary |
| 52-Week Change | VS. INDUSTRY | 18.66% | 20.68% | 8.61% | 54.61% |
| Market Cap | VS. INDUSTRY | $6.7B | $6.2B | $4.6B | $2.0B |
| Beta | VS. INDUSTRY | 0.9 | 0.8 | 1.1 | -- |
| Dividend Yield | VS. INDUSTRY | -- | -- | -- | -- |
| P/E (TTM, GAAP) | VS. INDUSTRY | 82.50x | 29.12x | 80.81x | 35.02x |
| Data as of | |||||
Fundamentals | |||||
| Total Revenue (TTM) | VS. INDUSTRY | $2.8B | $2.1B | $4.3B | $625.2M |
| Profit Margin | VS. INDUSTRY | 2.99% | 10.10% | 1.34% | 9.42% |
| Earnings Growth (5 year, GAAP) | VS. INDUSTRY | -- | 14.67% | -- | -- |
| Revenue Growth (TTM) | VS. INDUSTRY | 34.79% | 16.10% | 115.91% | 44.81% |
| Data as of |
Copyright © 2018. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.